Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXZ1OK
|
||||
| Drug Name |
[3-(5-Fluoro-1H-indol-3-yl)-propyl]-[2-(quinolin-5-yloxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL126536
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H22FN3O
|
||||
| Canonical SMILES |
Fc1ccc2[nH]cc(CCCNCCOc3cccc4ncccc34)c2c1
|
||||
| InChI |
InChI=1S/C22H22FN3O/c23-17-8-9-21-19(14-17)16(15-26-21)4-2-10-24-12-13-27-22-7-1-6-20-18(22)5-3-11-25-20/h1,3,5-9,11,14-15,24,26H,2,4,10,12-13H2
|
||||
| InChIKey |
FKQLIZKVHZDRRD-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.